Proton therapy for prostate cancer: A review of the rationale, evidence, and current state
- PMID: 30527342
- DOI: 10.1016/j.urolonc.2018.11.012
Proton therapy for prostate cancer: A review of the rationale, evidence, and current state
Abstract
Men diagnosed with localized prostate cancer have many curative treatment options including several different radiotherapeutic approaches. Proton radiation is one such radiation treatment modality and, due to its unique physical properties, offers the appealing potential of reduced side effects without sacrificing cancer control. In this review, we examine the intriguing dosimetric rationale and theoretical benefit of proton radiation for prostate cancer and highlight the results of preclinical modeling studies. We then discuss the current state of the clinical evidence for proton efficacy and toxicity, derived from both large claim-based datasets and prospective patient-reported data. The result is that the data are mixed, and clinical equipoise persists in this area. We place these studies into context by summarizing the economics of proton therapy and the changing practice patterns of prostate proton irradiation. Finally, we await the results of a large prospective randomized clinical trial currently accruing and also a large prospective pragmatic comparative study which will provide more rigorous evidence regarding the clinical and comparative effectiveness of proton therapy for prostate cancer.
Keywords: Prostate; Protons; Radiation.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
